Press Releases
- Active Biotech adjusts the terms in the announced rights issue
- NOTICE OF EXTRAORDINARY GENERAL MEETING
- Active Biotech announces a rights issue of SEK 35 million
- Active Biotech reports intriguing intraocular concentrations achieved in a clinical biodistribution study of laquinimod eye drops
- Active Biotech Interim Report Q2 2024